Market closed

Dynavax/$DVAX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Dynavax

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Ticker

$DVAX
Trading on

Industry

Biotechnology

Employees

405

Dynavax Metrics

BasicAdvanced
$1.6B
63.25
$0.20
1.32
-
$1.6B
1.32
$14.63
$9.74
2.6M
10.796
9.679
41.931
42.63
0.13%
0.06%
4.48%
63.25
5.934
2.66
2.67
27.345
19.36%
-500.00%
-14.23%
-29.43%

What the Analysts think about Dynavax

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Dynavax stock.
0.00%20.00%40.00%60.00%80.00%100.00%JulAugSeptOctNovDecJanFebMarAprMayJun

Dynavax Financial Performance

$0$10B$20B$30B$40B$50B$60BQ4 23Q1 24Q2 24Q3 24

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Dynavax Earnings Performance

$0.00$1.00$2.00$3.00Q4 23BeatQ1 24BeatQ2 24BeatQ3 24BeatQ4 24-

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $DVAX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Dynavax stock?

Dynavax (DVAX) has a market cap of $1.6B as of April 06, 2025.

What is the P/E ratio for Dynavax stock?

The price to earnings (P/E) ratio for Dynavax (DVAX) stock is 63.25 as of April 06, 2025.

Does Dynavax stock pay dividends?

No, Dynavax (DVAX) stock does not pay dividends to its shareholders as of April 06, 2025.

When is the next Dynavax dividend payment date?

Dynavax (DVAX) stock does not pay dividends to its shareholders.

What is the beta indicator for Dynavax?

Dynavax (DVAX) has a beta rating of 1.32. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Can we use optional cookies? View our Cookie Policy for details.

pixel